Ra Medical Systems, Inc.
Ra Medical Systems, Inc. (RMED), relating to its proposed merger with Catheter Precision, Inc. Under the terms of the agreement, RMED shareholders are expected to own approximately 20% of the combined company
Ra Medical Systems, Inc. (RMED), relating to its proposed merger with Catheter Precision, Inc. Under the terms of the agreement, RMED shareholders are expected to own approximately 20% of the combined company
STORE Capital Corp. (STOR), relating to its proposed acquisition by GIC and funds managed by Oak Street. Under the terms of the agreement, STOR shareholders are expected to receive $32.25 in cash per share they own.
Turquoise Hill Resources Ltd. (TRQ), relating to its proposed acquisition by Rio Tonto Group. Under the terms of the agreement, TRQ shareholders are expected to receive C$43.00 in cash per share they own
Signify Health, Inc. (SGFY), relating to its proposed acquisition by CVS Health Corp. Under the terms of the agreement, SGFY shareholders are expected to receive $30.50 in cash per share they own.
Meridian Bioscience, Inc. (VIVO) relating to its proposed acquisition by SD Biosensor, Inc. and SJL Partners LLC. Under the terms of the agreement, VIVO shareholders will receive $34.00 in cash per share they own.
Brigham Minerals, Inc. (MNRL), relating to its proposed merger with Sitio Royalties Corp. Under the terms of the agreement, MNRL shareholders are expected to receive 1.133 shares of combined company per share they own.
ChannelAdvisor Corp. (ECOM), relating to its proposed acquisition by CommerceHub. Under the terms of the agreement, ECOM shareholders are expected to receive $23.10 in cash per share they own
Centric Financial Corp. (CFCX), relating to its proposed merger with First Commonwealth Financial Corp. Under the terms of the agreement, CFCX shareholders are expected to receive 1.09 shares of First Commonwealth per share they own
Forma Therapeutics Holdings, Inc. (FMTX), relating to its proposed acquisition by Novo Nordisk A/S. Under the terms of the tender offer, FMTX shareholders are expected to receive $20.00 in cash per share they own.
Gemini Therapeutics, Inc. (GMTX), relating to its proposed merger with Disc Medicine, Inc. Under the terms of the agreement, GMTX shareholders are expected to own 28% of the newly combined company.